Lundbeck
Morten Grunnet, Prof, PhD, DrSci, is the Vice President and Head of Neuroscience at Lundbeck, overseeing pre-clinical biological research with a focus on neuroinflammation, hormonal signaling, protein aggregation, and neuronal biology. Concurrently, Morten serves as an honorary professor at the University of Copenhagen and is the co-founder and Chief Scientific Officer of Acesion Pharma, a biotech firm dedicated to advancing treatments for atrial fibrillation. Previous roles include leadership positions at NeuroSearch A/S and multiple academic appointments at the University of Copenhagen, where Morten contributed to various research initiatives and managed research teams. Morten obtained a PhD, DrSci from the University of Copenhagen, further solidifying expertise in the biomedical field.
This person is not in any teams
Lundbeck
42 followers
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.